We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

76 hedge funds and large institutions have $782M invested in Dianthus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,850% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 2

634% more capital invested

Capital invested by funds: $107M → $782M (+$676M)

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

200% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 8

95% more funds holding

Funds holding: 39 → 76 (+37)

19.41% more ownership

Funds ownership: 69.44% → 88.85% (+19%)

Holders
76
Holders Change
+37
Holders Change %
+94.87%
% of All Funds
1.09%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
39
Increased
24
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$65M
2
RCM
RA Capital Management
Massachusetts
+$50.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.2M
4
APM
Avidity Partners Management
Texas
+$32.6M
5
VA
VR Adviser
New York
+$25.4M

Top Sellers

1
TCM
Tang Capital Management
California
-$5.21M
2
5VM
5AM Venture Management
California
-$5M
3
NCM
Nantahala Capital Management
Connecticut
-$3.42M
4
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$1.09M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$302K
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
76
Macquarie Group
Australia
$55 +$39.6K +1,824 New
NCM
77
Nantahala Capital Management
Connecticut
– -$3.42M -328,433 Closed
ACM
78
ADAR1 Capital Management
Texas
– -$5K -481 Closed
1 2 3
4